Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Including valve
Reexamination Certificate
2001-10-30
2004-02-17
McDermott, Corrine (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Including valve
C623S001250
Reexamination Certificate
active
06692523
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the percutaneous treatment of vessels by an apparatus and method wherein the apparatus is delivered via catheter and comprises a surgical graft which is fixated in a vessel by means of a chemical or mechanical hardening-filler material system.
2. General Background
Previous methods of treating aortic aneurysms include treatment via surgical procedure in which an incision is made in the abdomen or chest of the patient, the diseased area is cleaned by the surgeon and an artificial graft is sutured in place. This highly invasive procedure usually results in long hospital stays and lengthy recoveries. Further, mortality and morbidity complications often result as a consequence of this surgical procedure.
Other percutaneous methods have been attempted, such as are disclosed in U.S. Pat. No. 4,577,631 (utilizing occlusion catheters with pressure sensitive adhesives), U.S. Pat. No. 4,740,207 (self-expanding stent-type materials) and U.S. Pat. Nos. 4,271,839, 4,776,337 and 4,762,132 (other stent derived devices).
There still exists a need, however, for a simple method of repairing a vessel with an intravascular graft which allows normal tissue ingrowth to occur at the repair site. There exists a specific need for a percutaneous approach in which a catheter could be loaded with a surgical graft that can be fixated in a vessel such as the aorta.
SUMMARY OF THE INVENTION
The present invention provides devices for repairing aortic aneurysms and the like. The intraluminal graft of the present invention in one embodiment comprises a flexible linear or bifurcated tubular sleeve delivered to a repair site in a body by suitable means such as a catheter. The sleeve is suitably made of woven or cast material, and has peripheral conduits or tubes at each end. Each conduit has at least a single port that is connected to an elongated introduction means associated with the catheter delivery means. The introduction means may be attached to the outer surface of the sleeve. The collapsed sleeve may be made rigid and circular by the introduction through the introduction means of a chemical or mechanical hardening means.
The chemical hardening means may be a polymeric material introduced through the introduction means through an external source, such as a catheter or syringe. Alternatively, the mechanical hardening means may comprise a single wire or multiple wires inserted into the conduits to support the ends, or any portion of the sleeve. The wires are not attached to the sleeve but reside in the conduits to provide a constant spring tension. The wires may be of any suitable material which retains its tension, such as spring wire or memory wire.
The introduction means may be detached from the sleeve after introduction of the chemical or mechanical hardening means.
The sleeve may alternatively be associated with a fixation means comprising either a series of cylindrical tubules or an enclosure which fits over the sleeve, with a hardening-filler system enclosed therein. The hardening-filler system includes an activatable hardening material which may be provided in the form of microspheres that upon external agitation may be disrupted, allowing the contents to react together and form a hardened material that fills the tubules or enclosure, thereby expanding and rigidifying the fixation means, and fixing the sleeve in place in the site of repair. Polymeric materials which are activatable include thioisocyanates, aldehydes, isocyanates, divinyl compounds, epoxides or acrylates. In addition to the aforementioned, photoactivatable crosslinkable groups as succinimidyl azido salicylate, succinimidyl-azidobenzoate, succinimidyl dithio acetate, azidoiodobenzene, fluoro nitrophenylazide, salicylate azides, benzophenone-maleimide, and the like may be used as photoactivatable crosslinking reagents. The material may also consist of a thin coating which can be activated by external forces such as laser, radio frequency, ultrasound or the like, with the same hardening result taking place. These materials would allow for normal tissue ingrowth to take place.
REFERENCES:
patent: 3631854 (1972-01-01), Fryer
patent: 3991767 (1976-11-01), Miller, Jr. et al.
patent: 4141364 (1979-02-01), Schultze
patent: 4183102 (1980-01-01), Guiset
patent: 4271839 (1981-06-01), Fogarty et al.
patent: 4434797 (1984-03-01), Silander
patent: 4577631 (1986-03-01), Kreamer
patent: 4580568 (1986-04-01), Gianturco
patent: 4740207 (1988-04-01), Kreamer
patent: 4741872 (1988-05-01), DeLuca et al.
patent: 4762132 (1988-08-01), Nicolas et al.
patent: 4776337 (1988-10-01), Palmaz
patent: 4871365 (1989-10-01), Dumican
patent: 5123917 (1992-06-01), Lee
patent: 5151105 (1992-09-01), Kwan-Gett
patent: 5156620 (1992-10-01), Pigott
patent: 5282824 (1994-02-01), Gianturco
patent: 5330528 (1994-07-01), Lazim
patent: 5334201 (1994-08-01), Cowan
patent: 5370691 (1994-12-01), Samson
patent: 5464419 (1995-11-01), Glastra
patent: 5507770 (1996-04-01), Turk
patent: 5529653 (1996-06-01), Glastra
patent: 5536274 (1996-07-01), Neuss
patent: 5554119 (1996-09-01), Harrison et al.
patent: 5554180 (1996-09-01), Turk
patent: 5562727 (1996-10-01), Turk et al.
patent: 5676685 (1997-10-01), Razavi
patent: 5716397 (1998-02-01), Myers
patent: 5725547 (1998-03-01), Chuter
patent: 5741324 (1998-04-01), Glastra
patent: 5766203 (1998-06-01), Imran et al.
patent: 5800524 (1998-09-01), Borghi
patent: 5800538 (1998-09-01), Slepian et al.
patent: 6053943 (2000-04-01), Edwin et al.
patent: 6059823 (2000-05-01), Holman et al.
patent: 6312462 (2001-11-01), McDermott et al.
patent: 6355063 (2002-03-01), Calcote
patent: 6395019 (2002-05-01), Chobotov
patent: 6428566 (2002-08-01), Holt
patent: 28 05 749 (1978-08-01), None
patent: 0 441 516 (1991-08-01), None
patent: 0 617 930 (1994-05-01), None
patent: 0 502 905 (1994-09-01), None
patent: 0 664 107 (1995-07-01), None
patent: WO89/09031 (1989-10-01), None
patent: WO 91/07927 (1991-06-01), None
patent: WO96/10967 (1996-04-01), None
patent: WO97/03624 (1997-02-01), None
patent: 97/19653 (1997-06-01), None
patent: 97/00073 (1999-01-01), None
U.S. patent application Ser. No. 08/600834, Holman et al., filed Feb. 13, 1996.
U.S. patent application Ser. No. 09/111264, Holman et al., filed Jul. 6, 1998.
U.S. patent application Ser. No. 09/566335, Holman et al., filed May 8, 2000.
Bilge Fertac
Buscemi Paul J.
Donabedian David H.
Holman Thomas J.
Thometz Darlene A.
McDermott Corrine
Sci-Med Life Systems, Inc.
Stewart Alvin
Vidas Arrett & Steinkraus P.A.
LandOfFree
Endovascular apparatus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endovascular apparatus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endovascular apparatus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3329278